No abstract available
Publication types
-
Letter
-
Observational Study
MeSH terms
-
Adalimumab / therapeutic use
-
Biomarkers / metabolism
-
Dermatologic Agents / therapeutic use*
-
Epigenesis, Genetic / physiology
-
Etanercept / therapeutic use
-
Female
-
Humans
-
Infliximab / therapeutic use
-
Male
-
Middle Aged
-
Prospective Studies
-
Psoriasis / drug therapy*
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
Substances
-
Biomarkers
-
Dermatologic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab
-
Etanercept